103 studies found for:    "Malignant mesothelioma"
Show Display Options
Rank Status Study
1 Completed Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
Conditions: Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma;   Stage IA Malignant Mesothelioma;   Stage IB Malignant Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
2 Active, not recruiting Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma
Conditions: Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Drug: tivantinib;   Other: laboratory biomarker analysis
3 Completed
Has Results
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Localized Malignant Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Intervention: Drug: cediranib maleate
4 Completed Gefitinib in Treating Patients With Malignant Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: gefitinib;   Other: laboratory biomarker analysis
5 Completed Capecitabine in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: capecitabine
6 Completed Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
Condition: Malignant Mesothelioma
Intervention: Drug: raltitrexed
7 Completed SU5416 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: semaxanib
8 Completed Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Drug: cisplatin
9 Completed Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Metastatic Cancer
Interventions: Other: talc;   Procedure: therapeutic thoracoscopy;   Procedure: therapeutic videothoracoscopy
10 Completed
Has Results
Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: dasatinib
11 Completed PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
12 Completed Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Perioperative/Postoperative Complications
Interventions: Procedure: quality-of-life assessment;   Procedure: standard follow-up care;   Radiation: radiation therapy
13 Unknown  A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: Tremelimumab
14 Recruiting The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: Tremelimumab
15 Completed S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Intervention: Drug: gemcitabine hydrochloride
16 Recruiting Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
Condition: Unresectable Pleural or Peritoneal Malignant Mesothelioma
Interventions: Drug: Tremelimumab;   Drug: Placebo
17 Completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Localized Malignant Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Biological: bevacizumab;   Other: placebo;   Other: laboratory biomarker analysis
18 Completed Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: Valproate plus doxorubicin
19 Completed Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
20 Completed PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: belinostat;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years